ITM Isotope Technologies Munich SE, a pioneering leader in biotechnology and radiopharmaceuticals, has successfully raised an impressive €188 million in its latest funding round. With an unwavering passion for precision and commitment to revolutionizing cancer treatment, ITM focuses on the development and production of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes. Since its establishment in 2004, the company has made significant strides in creating a robust global supply network and GMP manufacturing capabilities to support a new generation of cancer therapies. The recent funding will accelerate ITM’s ambitious projects, including advancing its proprietary portfolio and clinical pipeline aimed at treating various challenging cancers such as neuroendocrine tumors, glioblastoma, and folate receptor α positive tumors found in lung, ovarian, and breast cancer. This investment reflects the growing confidence in ITM’s innovative approaches to precision oncology and the potential for significant improvement in patient outcomes. In collaboration with esteemed scientific and medical partners worldwide, ITM is dedicated to enhancing the quality of life for cancer patients by minimizing side effects while optimizing health economics through its pioneering Targeted Radionuclide Therapies. As the company sets its sights on an impactful future, this funding will play a vital role in fulfilling its mission to redefine cancer treatment paradigms globally. For further insights and updates, visit www.itm-radiopharma.com.
ITM Radiopharma Secures $188 Million Investment to Fuel Precision Oncology Passion
Recently funded · €188.0MHealthcare
Get the full ITM Radiopharma company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
